Home

Bioethics

BIO Policy Statement Regarding Genetic Privacy

BIO supports the creation of federal standards to protect the confidentiality of an individual's medical information, including the results of genetic testing.

BIO's Recommendations for National Privacy Legislation

The Biotechnology Industry Organization (BIO) supports national legislation to protect the confidentiality of all individually identifiable medical information. BIO believes that this medical information must be respected, treated confidentially and safeguarded from discriminatory misuse.

Letters, Testimony & Comments

BIO Statement to the Presidential Commission for the Study of Bioethical Issues: Principles Regarding Ethical Performance of International Clinical Trials
November 16 2011
Given by Russell M. Medford, MD, PhD President and CEO, Salutria Pharmaceuticals, LLC BIO Board Standing Committee on Bioethics Co-...
BIO Comments, National Institutes of Health: Promoting Objectivity in Research for Which Public Health Service Funding is Sought and Responsible Prospective Contractors
July 7 2009
BIO Comments, Draft National Institutes of Health Guidelines for Human Stem Cell Research
May 27 2009
Re: Draft National Institutes of Health Guidelines for Human Stem Cell Research (FR Doc. E9-9313) Dear Sir/Madam: The Biotechnology...
The Stem Cell Research Enhancement Act
June 6 2007
BIO Letter to Speaker Pelosi regard BIO's support for S. 5
BIO Support for S.5, the Stem Cell Research Enhancement Act
April 10 2007
Letter to Senate Majority Leader Henry Reid
More Letters, Testimony & Comments →

Press Releases

Biotech Leader Provides Testimony on Bioethical Issues in International Clinical Trials
November 17 2011
WASHINGTON, D.C. (Thursday, November 17, 2011) - Russell M. Medford, MD, PhD, President and CEO of Salutria...
BIO Welcomes Recommendations on Synthetic Biology from Presidential Commission for the Study of Bioethical Issues
December 16 2010
WASHINGTON, D.C. (Thursday, December 16, 2010) - Research and development in synthetic biology is an evolution of...
BIO Hails Court of Appeals Action to Lift Injunction on Embryonic Stem Cell Research
September 29 2010
WASHINGTON, D.C. (Wednesday, September 29, 2010) - Biotechnology Industry Organization (BIO) President and CEO Jim...
BIO Comments on Court Injunction Blocking Federal Funding of Embryonic Stem Cell Research
August 24 2010
WASHINGTON, D.C. (Tuesday, August 24, 2010) - Biotechnology Industry Organization (BIO) President and CEO Jim...
Synthetic Biology and its Practical Applications to Be Highlighted at World Congress on Industrial Biotechnology and Bioprocessing
May 24 2010
WASHINGTON, D.C. (Monday, May 24, 2010) - Achievement of a milestone in creating synthetic life in the form of a...
More Press Releases →